MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from credit
facility, net of issuance...
$46,411K
Net cash provided by
(used in) financing...
$37,675K
Canceled cashflow
$8,736K
Net decrease in
cash, cash...
-$23,127K
Canceled cashflow
$37,675K
Accounts receivable,
prepaid expenses, and...
-$86,243K
Non-cash stock-based
compensation
$7,724K
Depreciation and
amortization
$3,062K
Impairment of long-lived
assets
$266K
Proceeds from maturities
of marketable...
$147,289K
Proceeds from assets held
for sale
$39,750K
something is missing
-$4,468K
Net proceeds from
the exercise of...
-$3,690K
Finance lease payments
$578K
Net cash used in
operating activities
-$32,423K
Canceled cashflow
$97,295K
Net cash used in
investing activities
-$28,361K
Effect of exchange rate
on cash, cash...
-$18K
Canceled cashflow
$187,039K
Accounts payable,
accrued expenses, and...
-$60,078K
Deferred revenue
-$50,951K
Net income (loss)
-$9,491K
Other items, net
$8,972K
Inventory
$226K
Purchases of marketable
securities
$214,130K
Capital expenditures,
including internal-use...
$1,270K
Back
Back
Cash Flow
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)
source: myfinsight.com